Abpro receives FDA clearance for cancer drug trial Jan 6, 2026 07:00AM
Abpro receives NASDAQ listing extension to regain compliance Dec 9, 2025 07:00AM
Abpro Holdings (ABP) files for 9.78M share offering by selling stockholders Nov 7, 2025 07:44AM
Abpro and Celltrion to present HER2×CD3 therapy data at SITC 2025 Nov 4, 2025 09:19AM